Modeling suggests that ART will result in greater reductions in tuberculosis incidence if started at CD4 cell counts of 500 cells/μl [21], but guidelines in Brazil and most countries recommend initiating treatment later [11]. This evidence concerns the gene CD4 and tuberculosis.